Lung-on-a-Chip

The lung-on-chip may replace laboratory animal tests......
Emulate launches to commercialize automated human Organs-on-Chips platform to accelerate drug development, detect toxicities and advance personalized medicine.

Company founded by Organs-on-Chips pioneers; secures $12 million in Series A financing to develop innovative products that emulate human physiology.

Lung-on-a-Chip

Combining microfabrication techniques with innovative engineering and biology, the Organs-on-Chips offer a new approach to bioemulation by mimicking the complex mechanical and biochemical environment required for organ-level function. This video of the Lung-on-Chip demonstrates how we mimicked human biology and disease on the chip.

“Emulate’s Organs-on-Chips platform provides, for the first time, a window into the inner-workings of human organs without having to invade a living body,” said James Coon, Chief Executive Officer of Emulate. “Our unique automated Organs-on-Chips approach to human bioemulation opens up entirely new possibilities to develop products with enhanced properties, improved efficacy and safety, and personalization to patients and consumers. The company will focus on key strengths of integrating design, biology and engineering to create revolutionary products. We are launching Emulate to be a leader in advancing innovative product design across multiple industries including drug development, healthcare, agriculture and consumer health.”